If your child has been diagnosed with ADHD and a doctor has suggested medication, there is a good chance someone has already warned you about it. A relative, a neighbour, something you read. The worry is almost always the same: if you give a child a stimulant now, are you setting them up to misuse drugs later?
It is a fair question. It has also been studied properly, and the answer is clearer than most of what you will read online.
The short answer
Research has not found that treating ADHD with stimulant medication increases the risk of developing a substance use disorder later in life.
Some large studies suggest treatment may actually lower that risk. Other carefully designed studies find no difference either way. What no credible study has found is harm.
That last point is worth sitting with, because it is the one that answers the worry people actually have.
Where the worry came from
The concern has a name in the research literature. It is called the sensitisation hypothesis.
The idea was that giving a developing brain a stimulant early might make it more responsive to drugs later — effectively priming the reward system. It was a reasonable thing to test. Stimulants act on the same brain chemistry that substances of misuse act on, so the question was worth asking properly rather than dismissing.
It was asked properly. It did not hold up.
What the research found
The evidence splits into two groups, and it is worth understanding why they differ rather than picking whichever one you prefer.
Studies that found a protective effect
Large national registry studies from Sweden — which track very large numbers of people over long periods using health records — show a marked reduction in substance misuse among people treated with stimulant medication. Longer treatment duration was associated with lower rates.
An earlier meta-analysis, published in 2003, pooled follow-up studies of children and adolescents treated with stimulants and found roughly a 1.9-fold reduction in the risk of substance use disorders in the treated group. The protective effect appeared considerably larger in adolescents than in adults, which suggests timing may matter.
Both of these findings are discussed in a 2018 review in the American Journal of Psychiatry, linked in the references below.
Studies that found no effect in either direction
In 2013, researchers published a meta-analysis in JAMA Psychiatry that pooled 15 longitudinal studies covering 2,565 individuals. It found comparable outcomes between children who had been treated with medication and those who had not, across every substance category examined. Not better. Not worse.
A prospective cohort study published in JAMA Psychiatry in 2023 followed participants through adolescence into early adulthood and adjusted for factors that earlier studies had not fully accounted for — including the fact that stimulant use tends to fall during exactly the years when substance use tends to rise. It found no association between stimulant treatment and later frequent use of alcohol, cannabis, tobacco or other substances.
Why the two groups disagree
Registry studies capture enormous numbers of people but cannot fully separate the effect of the medication from the reasons a particular person received it. Prospective studies follow people more carefully but involve far smaller numbers.
Both approaches have real limitations. What matters is that they point in the same general direction: no harm, with the possibility of benefit.
What this means about stimulant misuse
Two findings are worth stating plainly, because they are commonly misunderstood.
The large majority of people prescribed stimulant medication do not misuse it.
And where early stimulant misuse does occur, it tends to be a marker of an emerging substance use problem rather than the cause of one. People who misuse stimulants generally misuse other substances too. The medication is often a signal, not the origin.
The point that usually gets missed
Most of this debate is framed as though the choice is between medication with some unknown risk and no medication with no risk.
That is not the choice.
Untreated ADHD is itself associated with elevated risk of substance use problems. The difficulties that come with it — impulsivity, poor planning, academic failure, job instability, damaged self-esteem — are the same conditions that reliably precede substance use. Leaving ADHD untreated is not a neutral option.
So the reasoning that makes sense in clinic is this. Treat the ADHD because untreated ADHD carries its own risks and because treatment improves function. If there is also a protective effect against later substance use, that is a benefit rather than the reason for treating.
The prevention argument is not the indication.
If you are a parent
A few things that are reasonable to hold on to.
The fear that medication creates future addiction is not supported by the research. It is one of the most examined questions in child psychiatry.
Age at starting treatment appears to matter in some studies, with larger protective effects seen in adolescence than in adulthood. This is one reason that delaying assessment in the hope that a child will grow out of it is not risk-free.
Medication is one part of treatment, not the whole of it. Any decision should be made with a psychiatrist who has assessed your child properly, not on the basis of an article — including this one.
If you are an adult with ADHD and a history of substance use
This is a more complicated situation and it deserves individual assessment rather than a general rule.
The presence of a current or past substance use disorder changes how treatment is planned — what is prescribed, in what order, and with what monitoring. It does not automatically rule out treating the ADHD. Many people in this position have gone years with the ADHD unrecognised, having been treated only for the substance use.
If this describes you, the useful step is an assessment with a psychiatrist who works across both areas, rather than deciding in advance that treatment is off the table.
Frequently asked questions
Do ADHD medications cause addiction? Research has not found that stimulant treatment for ADHD increases the risk of later substance use disorder. Some large studies suggest a reduced risk, while other well-designed studies find no effect in either direction.
Is it safer to leave ADHD untreated? No. Untreated ADHD is itself associated with elevated risk of substance use problems, alongside difficulties with education, work and self-esteem. Leaving it untreated is not a risk-free choice.
Does the age at which treatment starts matter? Some studies suggest protective effects are larger when treatment begins in adolescence than in adulthood, though this is not consistent across all the research.
Can someone with a history of addiction be treated for ADHD? Often yes, but it requires individual assessment. The treatment plan, sequencing and monitoring differ from someone without that history.
A note on this article
This article is general information and not a substitute for individual medical advice. Research in this area continues, and findings can change. Decisions about medication should be made with a qualified psychiatrist who has assessed you or your child directly.
References
-
Faraone SV, Wilens TE, et al. Drug Treatments for ADHD Reduce Risk of Substance Use Disorders. American Journal of Psychiatry, 2018. https://www.psychiatryonline.org/doi/10.1176/appi.ajp.2017.17070733
-
Humphreys KL, Eng T, Lee SS. Stimulant Medication and Substance Use Outcomes: A Meta-analysis. JAMA Psychiatry. 2013;70(7):740–749. https://jamanetwork.com/journals/jamapsychiatry/fullarticle/1691781
-
Association Between Stimulant Treatment and Substance Use Through Adolescence Into Early Adulthood. JAMA Psychiatry. 2023;80(9):933–941. https://jamanetwork.com/journals/jamapsychiatry/fullarticle/2806881
-
Wilens TE, et al. ADHD, substance use disorders and stimulant treatment: understanding the relationships. World Psychiatry, 2024. https://onlinelibrary.wiley.com/doi/10.1002/wps.21348
